Gritstone bio, Inc.
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid t…
Biotechnology
US, EmeryVille [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Gritstone bio, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDGritstone bio, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Gritstone bio, Inc..
If you want to see a demo, head over to the financial segments of AAPL